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Abstract
Exposure of mice to UV radiation results in suppression of the contact hypersensitivity (CHS) response. Here, we
report that the UV-induced suppression of CHS is associated with increases in the levels of cyclooxygenase-2
(COX-2), prostaglandin E2 (PGE2), and PGE2 receptors in the exposed skin. UV radiation–induced suppression of
CHS was inhibited by topical treatment of the skin with celecoxib or indomethacin (inhibitors of COX-2) or AH6809
(an EP2 antagonist). Moreover, mice deficient in COX-2 were found to be resistant to UV-induced suppression of CHS.
The exposure of wild-typemice to UVB radiation resulted in DNA hypermethylation, increased DNAmethyltransferase
(Dnmt) activity, and elevated levels of Dnmt1, Dnmt3a, and Dnmt3b proteins in the skin, and these responses were
downregulated on topical treatment of the site of exposure after irradiation with indomethacin or EP2 antagonist.
Topical treatment of UVB-exposed COX-2–deficient mice with PGE2 enhanced the UVB-induced suppression of
CHS as well as global DNA methylation and elevated the levels of Dnmt activity and Dnmt proteins in the skin. Intra-
peritoneal injection of 5-aza-2′-deoxycytidine (5-Aza-dc), a DNA demethylating agent, restored the CHS response to
2,4-dinitrofluorobenzene in UVB-exposed skin and this was associated with the reduction in global DNA methylation
and Dnmt activity and reduced levels of Dnmt proteins. Furthermore, treatment with 5-Aza-dc reversed the effect of
PGE2 on UV-induced suppression of CHS in COX-2–deficient mice. These findings reveal a previously unrecognized
role for PGE2 in the promotion of UVB-induced immunosuppression and indicate that it is mediated through PGE2
regulation of DNA methylation.
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Introduction
It has been shown that UV radiation in the UVB (290–320 nm)
range induces immunosuppression in laboratory animals and that
xenografted tumor cells are more readily established and grow more
rapidly in UV-irradiated mice than mice that have not been UV
irradiated [1]. The exposure of the skin to UV radiation triggers the
release of prostaglandins (PGs), such as PGD2, PGF2α, and PGE2,
which are produced from arachidonic acid by the action of cyclo-
oxygenases (COX) [2,3]. The PGs have been implicated in UV
radiation–induced immunosuppression in several studies that show
that nonsteroidal anti-inflammatory drugs (NSAIDs), including indo-
methacin, that exert their effects through COX-2 inhibition can reverse
the immunosuppressive effect of UV radiation [4,5]. Among the PG
metabolites, PGE2, which is produced abundantly by keratinocytes
Abbreviations: 5-Aza-dc, 5-aza-2′-deoxycytidine; COX-2, cyclooxygenase-2; CHS, con-
tact hypersensitivity; DNFB, 2,4-dinitrofluorobenzene; Dnmt, DNA methyltransferase;
PGs, prostaglandins
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in UV-exposed skin [6,7], is the major and most effective metabolite
generated by COX-2 activity and is considered to be a potent medi-
ator of inflammatory responses. Collectively, these data suggest that
PGE2 plays a key role in UV radiation–induced immunosuppression.
The mechanisms by which PGE2 induces or promotes UV-induced
immunosuppression and the relationship of these mechanisms to those
of other proposed mediators of UV-induced immunosuppression have
not been elucidated fully, however.
These mechanisms are of considerable clinical interest as UV-induced
immunosuppression has been implicated as a risk factor for melanoma
and nonmelanoma skin cancers. Epidemiologic and clinical studies sug-
gest a link between inflammation and skin cancer [8] and also suggest
that the use of NSAIDs reduces the relative risk for developing skin
cancer [9]. NSAIDs exert their anti-inflammatory and anti-tumor pro-
moting effects, in part, by targeting PGs. It is known that UV radiation
induces the expression of COX-2 and production of PGE2 in mouse
skin. We have demonstrated previously that there is a distinct pattern
of DNA hypermethylation in UVB-exposed mouse skin and UVB-
induced skin tumors in mice that is associated with elevated expression
and activity of the DNA methyltransferase (Dnmt) 1, Dnmt3a, and
Dnmt3b [10]. Together, these data suggested the possibility that
PGE2 may be involved in the promotion of UVB-induced immuno-
suppression and that the PGE2 may act to promote the immuno-
suppression by enhancing the levels of DNA methylation.
To explore these possibilities, we used a combination of genetic and
pharmacological approaches to assess the role of PGE2 in standard
contact hypersensitivity (CHS) model of UVB-induced immuno-
suppression. We found that UV-induced up-regulation of COX-2/
PGE2 is involved in suppression of the CHS response in UV-exposed
mice. The role of PGE2 is supported by the evidence that COX-2–
deficient mice are resistant to UVB-induced suppression of CHS.
We also show that administration of PGE2 to the mice increases the
levels of global DNA methylation in UV-exposed skin and that this
increase in DNA methylation is associated with increased expression
and activity of Dnmts.
Materials and Methods
Animals
Female C3H/HeN mice (6–7 weeks old) were purchased from
Charles River Laboratory (Wilmington, MA). The COX-2–deficient
male and female heterozygous mice (COX-2+/−) were used in this
study and were bred using heterozygous × heterozygous in our animal
resource facility, as described [11]. The breeding pairs were kindly
provided by Dr Langenbach of the National Institutes of Environmen-
tal Health Sciences (National Institutes of Health). In some experi-
ments, wild-type littermates from this breeding strain were also used
in this study. The survival of COX-2–deficient heterozygous mice is
similar to that of wild-type mice and there are no gross phenotypical
differences as compared with their wild-type counterparts. All mice
were maintained under standard housing conditions of a 12-hour dark/
12-hour light cycle, a temperature of 24 ± 2°C, and relative humidity of
50 ± 10%. Food and water were provided ad libitum. The animal pro-
tocol used in this study was approved by the Institutional Animal Care
and Use Committee of the University of Alabama at Birmingham.
Antibodies and Reagents
Antibodies were purchased as follows: 5-methylcytosine (5-mC)
from Calbiochem, EMD Biosciences (New Jersey, NJ); Dnmt1,
Dnmt3a, and Dnmt3b from Imgenec Corporation (San Diego, CA);
COX-2, EP2, EP3, and EP4 from Santa Cruz Biotechnology (Dallas,
TX); EP1 from Abcam (Cambridge, MA), and DNA isolation kits were
purchased from Qiagen Inc (Valencia, CA). The positive controls of
EP1, EP2, EP3, and EP4 for Western blot analysis were obtained from
Santa Cruz Biotechnology. The Methylamp Global DNA Methyla-
tion Quantification Kit and the EpiQuik DNA Methyltransferase
Activity Assay Kit were purchased from Epigentek, Inc (New York,
NY). The PGE2 immunoassay kit was purchased from Cayman Chemi-
cal (Ann Arbor, MI). All other chemicals of analytical grade were
purchased from Sigma-Aldrich Chemical Co (St Louis, MO).
UVB Irradiation of Mice
The dorsal hairs of mice were trimmed or shaved with electric
clippers at least 24 hours before UVB exposure. The shaved backs of
the mice were UVB irradiated as described earlier [12] using a band
of four FS20 UVB lamps (Daavlin; UVA/UVB Research Irradiation
Unit, Bryan, OH) equipped with an electronic controller to regulate
UV dosage. The UV lamps emit UVB (280–320 nm;≈80% of total
energy) and UVA (320–375 nm; ≈20% of total energy) with UVC
emission being insignificant. The peak emission of UV radiation is at
314 nm. This UV unit enables us to enter the UV dose in millijoules
and variations in energy output are compensated automatically so that
the desired UV dose is delivered.
UVB-induced CHS Model and Assay
The shaved backs of the mice were exposed to UVB radiation
(150 mJ/cm2) on four consecutive days. Twenty-four hours after the
last UV exposure, the mice were sensitized by painting 25 μl of 0.5%
2,4-dinitrofluorobenzene (DNFB) in acetone/olive oil (4:1, vol/vol)
on the UVB-irradiated skin site. The CHS response was elicited 5 days
later by painting both surfaces of both ears of each mouse with 20 μl
of 0.2% DNFB in acetone/olive oil (4:1, vol/vol). The ear skin thick-
ness was measured 24 hours after the challenge using an engineer’s
micrometer (Mitutoyo, Tokyo, Japan) and was compared with the ear
thickness just before the challenge, as detailed previously [13,14]. Mice
that were not UV irradiated but were sensitized and challenged as de-
scribed served as a positive control. Mice that were not UV irradiated
and received only ear challenge without sensitization withDNFB served
as a negative control. During the UV exposure of the mice, the ears
of the mice were protected from the UV irradiation. The UV-induced
suppression of CHS was determined as described previously [13,14].
Each group consisted of four to five mice.
UVB Irradiation of Mice for the Biochemical Analysis
Including Epigenetic Regulators
The shaved backs of the mice were exposed to UVB radiation
(150 mJ/cm2) on four consecutive days with or without the treatment
with PGE2, COX-2 inhibitors, or EP2 antagonist. Twenty-four hours
after the last UV exposure, mice were sacrificed and dorsal skin samples
were collected for preparing the samples for biochemical analysis.
Treatment of Mice with PGE2, Indomethacin, Celecoxib,
and 5-Aza-2′-deoxycytidine
To assess the effect of PGE2 or COX-2 inhibitors (indomethacin
or celecoxib) on UVB-induced suppression of the CHS response, the
mice were treated topically with celecoxib (500 μg in 0.2 ml acetone)
[15,16], indomethacin (50 μg in 0.2 ml of acetone) [16,17], or
AH6809 (25 μg in 0.2 ml of acetone) [16,18], which were applied
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to the shaved dorsal skin 30 minutes before UVB exposure. PGE2
(50 μg in 0.2 ml of acetone) was applied to the COX-2–deficient
mouse skin after UVB exposure [16,17]. Control animals were treated
topically with acetone (0.2 ml of acetone). Some mice were adminis-
tered 5-aza-2′-deoxycytidine (5-Aza-dc; 1 mg/kg body weight) by intra-
peritoneal (i.p.) injection after exposure to UVB radiation [19]. Two
doses of 5-Aza-dc were administered: first dose of 5-Aza-dc was injected
i.p. after first UVB exposure of mice and second dose of 5-Aza-dc was
administered i.p. after third exposure of UVB irradiation of mice.
Dot-blot Analysis of 5-mC for DNA Methylation
Genomic DNA from skin samples was isolated, and dot-blot analy-
sis was performed as detailed previously [12]. Briefly, genomic DNA
(50 ng) was transferred to a positively charged nitrocellulose mem-
brane by vacuum dot-blot analysis (Bio-Dot Apparatus; Bio-Rad,
Hercules, CA) and fixed by baking the membrane for 30 minutes at
80°C. After blocking the nonspecific binding sites in blocking buffer,
the membrane was incubated with the antibodies specific for 5-mC
at room temperature for 1 hour. After washing, the membrane was
incubated with HRP-conjugated secondary antibody. The enhanced
chemiluminescence reagents were used to detect the circular bands
of 5-mC.
Analysis of Global DNA Methylation
Total genomic DNA was extracted from the mouse skin sam-
ples using the Qiagen amp DNAMini Kit (Qiagen Sciences, Valencia,
CA) following the manufacturer’s protocol. The levels of global DNA
methylation were determined using the Methylamp Global DNA
Methylation Quantification Kit (Epigentek, Inc) following the manu-
facturer’s instructions.
Assay of Dnmt Activity
Skin samples from different treatment groups were used to
prepare nuclear extracts. Nuclear extracts were prepared using the
EpiQuik Nuclear Extraction Kit (Epigentek, Inc), and Dnmt activity
was determined using the EpiQuik DNA Methyltransferase Activity
Assay Kit (Epigentek, Inc) according to the instructions provided by
the manufacturer.
Western Blot Analysis
The epidermis was separated from the whole skin as described
earlier [20] and pooled from two or three mice in each group (n =
4–5 per group). Lysates of the epidermis were prepared for Western
blot analysis as described previously [21]. Proteins (25–60 μg) were
resolved on 8% to 10% sodium dodecyl sulfate–polyacrylamide gel
electrophoresis and transferred onto nitrocellulose membranes. The
membranes were incubated in blocking buffer for 1 hour at room temper-
ature and then incubated with the primary antibodies in blocking buffer
overnight at 4°C. The membrane was then washed with phosphate-
buffered saline and incubated with HRP-conjugated secondary
antibody. Protein bands were visualized using the enhanced chemi-
luminescence detection reagents. Equal loading of proteins on the gel
was verified by reprobing the membrane with anti–β-actin or anti-
histone H3 antibody.
Immunoassay Analysis of PGE2
Skin samples were homogenized in 100 mM phosphate buffer
(pH 7.4) containing 1 mM EDTA and 10 μM indomethacin using a
polytron homogenizer (PT3100; Fisher Scientific, Pittsburg, PA). The
supernatants were collected for analysis of the levels of PGE2 using
the Cayman PGE2 Enzyme Immunoassay Kit (Cayman Chemical)
following the manufacturer’s protocol.
Statistical Analysis
The statistical significance of difference between the values of
control and treatment groups was determined using analysis of vari-
ance. P < .05 was considered as statistically significant.
Results
UV-induced Suppression of CHS Is Associated with an Increase
in the Levels of COX-2, PGE2, and PGE2 Receptors
It is well recognized that exposure of mice to UV radiation induces
suppression of the immune system or CHS response. We first verified
that exposure of C3H/HeN mouse skin to UV radiation on four con-
secutive days resulted in suppression of the CHS response to DNFB,
a skin contact sensitizer (Figure 1A). To determine the mechanism
of UV-induced suppression of CHS, we investigated whether UV-
induced suppression of CHS is associated with enhancement of the
levels of mediators of inflammation, such as COX-2. For this pur-
pose, mice were UVB irradiated for four consecutive days and sacrificed
24 hours after the last UVB irradiation. Skin samples from UVB-
irradiated and non–UVB-irradiated mice were collected, and skin
lysates were subjected to Western blot analysis. As shown in Figure 1,
Western blot analysis revealed that the expression of COX-2 was approxi-
mately 2.5-fold higher in UVB-exposed skin than in non–UVB-
exposed mouse skin (Figure 1B). The production of PGE2 metabolite
and the expression levels of PGE2 receptors also were higher in the
UVB-exposed skin than non–UVB-exposed mouse skin (Figure 1, C
andD). Positive controls of EP receptors were used for proper recogni-
tion of receptors during gel electrophoresis.
Treatment of Mice with COX-2 Inhibitors Prevents UVB-
Induced Suppression of CHS in Mice
To determine whether the induction of COX-2 in UVB-exposed
skin plays a role in UVB-induced suppression of immune reactions,
the effect of UVB radiation on CHS was determined in mice that
had been administered COX-2 inhibitors. As shown in Figure 2A,
topical administration of indomethacin (sixth bar) or celecoxib (seventh
bar) before each exposure to UVB resulted in inhibition of UVB-
induced suppression of the CHS response in the mice. Importantly,
treatment of mice with indomethacin or celecoxib did not affect the
CHS response to DNFB in non–UV-irradiated mice (third or fourth
bar). We also found that the production of PGE2 was significantly
lower (P < .001) in indomethacin- or celecoxib-treated UVB-exposed
mouse skin compared to UV-exposed skin that was not treated with
these COX-2 inhibitors (Figure 2B). As this suggested a role for
PGE2 in UVB-induced immunosuppression, we examined the effect
of the EP2 antagonist, AH6809, on UVB-induced suppression of
CHS in mice. Topical treatment of the skin site with AH6809 before
each exposure of UVB enhanced sensitization to DNFB in UVB-
exposed mice (Figure 2A, eighth bar) compared to the UVB-exposed
mice that were not treated with the AH6809 (fifth bar).
Effect of Indomethacin and EP2 Antagonist on DNA
Methylation in UVB-Irradiated Mouse Skin
Wepreviously have shown that exposure of themouse skin toUV radi-
ation results in aberrant DNA hypermethylation in the UVB-exposed
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skin and UVB-induced skin tumors in mice [10]. PGE2 regulates many
fundamental cellular functions and has been implicated in regulation of
DNAmethylation in fibroblasts [22]. Asmost of the biologic functions of
PGE2 are mediated through the PGE2 receptor EP2, we tested the effects
of PGE2 on global DNA methylation by using an EP2 antagonist to
block the action of PGE2 in UV-exposed skin. In these experiments,
the mice were UVB irradiated on four consecutive days with or without
topical application of indomethacin or the EP2 antagonist. The mice
were sacrificed 24 hours after the last UVB exposure and skin samples
were processed for analysis. Quantitative analysis of the global DNA
methylation levels showed that the DNA methylation in the UVB-
exposed skin was more than 2.5-fold higher than in the non–UVB-
exposed mouse skin (Figure 3A). Topical application of indomethacin
or EP2 antagonist before each exposure to UVB resulted in significantly
lower levels of global DNA methylation (P < .01) in the mouse skin
compared to the levels in mouse skin that was exposed to UVB radiation
in the absence of treatment with indomethacin or EP2 antagonist. This
Figure 2. COX-2 inhibitors (indomethacin and celecoxib) and an EP2
antagonist (AH6809) inhibit UVB-induced suppression of the CHS
response. Mice were exposed to UVB radiation, and the CHS re-
sponse was measured as described in Figure 1A, except that some
mice were treated by topical administration of the indicated agents
to the skin 30 minutes before each UVB irradiation as described in
Materials and Methods section. The change in ear skin thickness is
reported in millimeter (×10−2) as the mean ± SD, with n = 4 to 5
per group.Mice in treatment group 1 were not sensitizedwith DNFB
but were challenged with DNFB on the ear skin. Mice were treated
with indomethacin (sixth bar), celecoxib (seventh bar), or EP2 an-
tagonist (eighth bar). Significant CHS response versus UVB alone–
exposed group of mice (fifth bar), *P < .001. Indo, indomethacin;
CLX, celecoxib. (B) The levels of PGE2 in the dorsal skin samples
were determined using a PGE2 immunoassay kit. Significant inhibi-
tion versus UVB alone group, *P < .001. Data are shown as the
means ± SD.
Figure 1. Effect of UVB radiation on CHS response and the levels of
inflammatory mediators. The shaved dorsal skin of female C3H/
HeN mice was exposed to UVB radiation (150 mJ/cm2) on four
consecutive days as described in Materials and Methods section.
(A) The mice were sensitized to DNFB, and the CHS response to
application of DNFB on ear skin (challenge) was assessed by mea-
surement of the ear swelling response 24 hours later as described
in Materials and Methods section. The change in ear skin thickness
is reported in millimeter (×10−2) as the mean ± SD, with n = 4 to
5 per group. (B–D) The mice were exposed to UVB (150 mJ/cm2)
on four consecutive days and then sacrificed 24 hours after the
last UVB exposure. Dorsal skin samples from UVB-exposed and
non–UVB-exposed mice were collected for analysis. (B) The levels
of COX-2 were determined in lysates of the skin using Western blot
analysis. (C) The concentration of PGE2 was determined in homoge-
nates of the epidermis using an ELISA kit. PGE2 concentration is
expressed in terms of pg/mg protein as the mean ± SD. (D) The
levels of expression of the PGE2 receptors (EP1, EP2, EP3, and EP4)
were determined by Western blot analysis. To recognize and verify
the exact band of EP receptors, a positive control of individual EP
receptor was run on the same gel. For B to D, data are shown in
duplicates, and each sample was prepared by pooling the skin
biopsies from at least two mice in each group. Std., standards or
positive controls of EP receptors.
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observation was further verified by dot-blot analysis in which the levels
of DNA methylation were determined using an antibody specific for
5-mC (Figure 3B).
Effect of Indomethacin and EP2 Antagonist on Dnmt Activity
and Dnmt Proteins in UVB-Irradiated Mouse Skin
As Dnmts play a key role in DNA methylation, we determined the
effect of indomethacin on Dnmt activity in UVB-exposed skin. Mice
were exposed to UVB radiation on four consecutive days with and
without topical application of indomethacin or AH6809. They were
then sacrificed 24 hours after the last UV exposure, and skin samples
were prepared for the analysis of Dnmt activity and Dnmt proteins.
As shown in Figure 3C , Dnmt activity was significantly higher in the
UVB-exposed mouse skin (P < .001) than the non–UVB-exposed
mouse skin. Furthermore, the Dnmt activity was significantly lower
(P < .001) in indomethacin-treated UVB-exposed skin than UVB
alone–exposed mouse skin. To determine whether the indomethacin-
induced reduction in Dnmt activity was associated with reduced ex-
pression ofDnmt proteins, the levels of Dnmt proteins were determined
in the skin lysates using Western blot analysis. As shown in Figure 3D,
there was a reduction in the levels of Dnmt1, Dnmt3a, and Dnmt3b
proteins in the indomethacin-treated UVB-exposed skin as compared
with non–indomethacin-treated UVB-exposed skin.
To test directly whether PGE2 promotes UVB-induced suppression
of immune reactivity through DNA methylation, we treated mice with
EP2 antagonist before each exposure to UVB irradiation and analyzed
Dnmt activity and the levels of Dnmt proteins in skin samples. As
shown in Figure 3C , the levels of Dnmt activity were significantly
lower in the AH6809-treated UVB-exposed mouse skin (P < .001)
than in non–AH6809-treated UVB-exposed skin. Similarly, the levels
of Dnmt1, Dnmt3a, and Dnmt3b proteins, as determined by Western
blot analysis, were reduced in the AH6809-treated UVB-exposed mouse
skin (Figure 3D).
COX-2–deficient Mice Are Resistant to UVB-Induced
Suppression of CHS
If PGE2 promotes UVB-induced immunosuppression in mice, then
PGE2 deficiency in mice should prevent UVB-induced suppression of
CHS. Thus, to confirm the role of PGE2 in UVB-induced suppres-
sion of CHS, we used COX-2–deficient mice that are unable to pro-
duce sufficient PGE2 to adequately suppress the CHS response. The
COX-2–deficient mice were subjected to the CHS assay protocol as
described in Materials and Methods section. As shown in Figure 4,
the sensitization reactions after DNFB challenge (third bar) of the
COX-2–deficient mice after UVB exposure on four consecutive days
were almost equal to those of mice in the positive control group (second
bar), indicating that the COX-2–deficient mice are indeed resistant to
UVB-induced suppression of the CHS response. We have also ex-
amined the effect of UVB irradiation on the CHS response in wild-type
littermates of COX-2–deficient mice. Following CHS protocol, it was
observed that UVB irradiation of wild-type littermates resulted in sup-
pression of CHS response to DNFB, as was observed in C3H/HeN
Figure 3. Indomethacin and EP2 antagonist (AH6809) affect UVB-induced epigenetic regulators in UVB-irradiated mouse skin. Mice were
UVB exposed in the presence and absence of topical treatment of themouse skin with indomethacin or EP2 antagonist on four consecutive
days. Samples of the dorsal skin were collected 24 hour later. (A, B) Total DNA was extracted from the epidermis. (A) The levels of global
DNAmethylation were determined in skin samples using a Global DNAMethylation Kit. (B) The levels of 5-mC in the DNAwere estimated by
dot-blot analysis. (C) Nuclear extracts were prepared and total Dnmt activity was determined using the Dnmt Activity Assay Kit. Data are
presented in terms of percentage versus non–UVB-irradiated control skin. (D) The skin samples from the mice described in A were analyzed
for the presence of Dnmt1, Dnmt3a, and Dnmt3b proteins using Western blot analysis. Significant inhibition versus the group exposed to
UVB but not treated with indomethacin or PGE2 antagonist, *P < .001,
¶P < .01.
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mice (data not shown). To further verify the role of PGE2 in UVB-
induced immunosuppression, another group of COX-2–deficient mice
was exposed to UVB and treated with PGE2 as described in Materials
andMethods section. As shown in Figure 4, the COX-2–deficient mice
that were UVB irradiated and treated with PGE2 showed a significant
suppression of the CHS response (fourth bar) compared with the mice
that were not treated with PGE2 but exposed to UVB.
Treatment of Mice with the DNA Demethylating Agent,
5-Aza-dc, Abrogates PGE2-Induced Suppression of CHS
in UVB-Exposed COX-2–Deficient Mice
To test whether PGE2 promotes UVB-induced suppression of
CHS in mice by promoting DNA methylation, we treated another
group of COX-2–deficient mice with PGE2 and then with the DNA
demethylating agent 5-Aza-dc following the protocol described in
Materials and Methods section. As shown in Figure 4, treatment of
COX-2–deficient mice with PGE2 and subsequently with 5-Aza-dc
resulted in a full sensitization reaction after treatment of the mice with
DNFB (fifth bar), and this CHS response was comparable to that
observed in the positive control group (second bar). These data suggest
that PGE2-induced DNA methylation might be blocked or that
demethylation may occur in the mice treated with 5-Aza-dc resulting
in full sensitization and restoration of the CHS response.
Effect of PGE2 on DNA Methylation, Dnmt Activity, and
Dnmt1, Dnmt3a, and Dnmt3b Proteins in UVB-Exposed
Skin of COX-2–Deficient Mice
The results of the current study show that inhibition of PGE2 in
UVB-exposed skin by topical administration of indomethacin resulted
in reduced expression of global DNA methylation and Dnmt activity
and lowered the levels of Dnmt proteins (Figure 3). To further verify
that PGE2 affects epigenetic regulators on UVB exposure, we used the
COX-2–deficient mice. In these experiments, COX-2–deficient mice
were exposed to UVB radiation on four consecutive days with or
without topical treatment with PGE2, as detailed in Materials and
Methods section. Mice were sacrificed 24 hours after the last UVB
exposure and skin samples were collected for the analysis of epigenetic
biomarkers. As shown in Figure 5A, exposure of COX-2–deficient
mice to UVB did not significantly influence DNAmethylation. In con-
trast, the levels of global DNA methylation were significantly higher in
the UVB-exposed COX-2–deficient mice that were treated with PGE2
than in the UVB-exposed COX-2–deficient mice that were not treated
with PGE2. This effect of PGE2 on DNA methylation was further
verified by dot-blot analysis using antibody specific to 5-mC (Fig-
ure 5B). We also determined the effects of PGE2 on Dnmt activity
and Dnmt proteins (Dnmt1, Dnmt3a, and Dnmt3b) in the skin sam-
ples from these treatment groups. We found that the levels of Dnmt
activity were not significantly higher in the COX-2–deficient mice that
were exposed to UVB compared to the levels in the COX-2–deficient
mice that were not exposed to UVB. However, treatment of COX-2–
deficient mice with PGE2 resulted in significantly higher (P < .001)
levels of Dnmt activity in the UVB-exposed skin of the COX-2–
deficient mice compared to the levels of activity in the non–PGE2-
treated UVB-exposed COX-2–deficient mice (Figure 5C ). Similarly,
treatment with PGE2 enhanced the levels of Dnmt1, Dnmt3a, and
Dnmt3b proteins in the UVB-exposed COX-2–deficient mice (Fig-
ure 5D). Interestingly, the levels of the Dnmt3a protein in the UVB-
exposed PGE2-treated COX-2–deficient mouse skin were greater than
the levels of the Dnmt1 and Dnmt3b proteins. To further verify that
PGE2 is responsible for enhanced DNA methylation, the wild-type
littermates of COX-2–deficient mice were treated with PGE2 for four
consecutive days, then sacrificed 24 hours after the last treatment of
PGE2, and skin samples were collected for the analysis of global
DNA methylation levels. It was found that PGE2 treatment signifi-
cantly enhanced (P < .01) the levels of global DNA methylation in
PGE2-treated mouse skin compared to non–PGE2-treated control
skin (Figure 5E).
PGE2 Increases Dnmt3a Expression through Increased
Expression of Sp1 and Sp3
The expression of Dnmt3a can be regulated by the transcription
factors Sp1 and Sp3 [23]. To determine whether the marked PGE2-
induced increase in the levels of Dnmt3a protein is associated with
up-regulation of Sp1 and/or Sp3, we determined the expression of
these transcription factors in the skin of COX-2–deficient mice that
had been exposed to UVB with and without treatment with PGE2.
Western blot analysis revealed that UVB irradiation did not affect
the expression of Sp1 and Sp3 transcription factors in the COX-2–
deficient mice. Treatment of UVB-exposed COX-2–deficient mice
with PGE2 markedly increased the expression of both transcription
factors compared to the expression in either UVB-exposed COX-2–
deficient mice that were not treated with PGE2 or non–UVB-irradiated
mouse skin, as shown in Figure 5F . In contrast, the expression levels
of Sp1 and Sp3 were increased in UVB-irradiated skin of wild-type
littermates of COX-2–deficient mice compared to non–UVB-irradiated
control skin (Figure 5G ). These data suggest that PGE2-mediated
increase in Dnmt3a is due, at least in part, to increased expression of
the Sp1 and Sp3 transcription factors.
Figure 4. Effect of UVB irradiation on the CHS response in COX-2–
deficient mice. Mice were UVB irradiated on four consecutive days
with or without topical application of PGE2 after each UVB exposure
and the CHS response assessed 24 hours later, as described in Fig-
ure 1 and in Materials and Methods section. The COX-2–deficient
mice were resistant to UVB-induced suppression of the CHS re-
sponse. Topical application of PGE2 after each UVB exposure pro-
moted suppression of CHS in UV-exposed mice (fourth bar) and
treatment of the mice with a DNA demethylating agent 5-Aza-dc
(1 mg/kg body weight) by i.p. injection after exposure to UVB radia-
tion restored the CHS response in the PGE2-treated COX-2–deficient
mice. Significant suppression of CHS versus positive control group
(fourth bar), *P < .001. Significant restoration of CHS versus PGE2-
induced suppression of CHS, ¶P < .01.
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Effect of DNA Demethylating Agent (5-Aza-dc) on
UVB-Induced Suppression of CHS in C3H/HeN Mice
To verify whether PGE2-enhanced DNA methylation and Dnmt
activity have a role in UVB-induced CHS in mice, additional experi-
ments were conducted. Mice were exposed to UVB with and without
treatment with 5-Aza-dc and the CHS response to DNFB was evalu-
ated, as detailed in Materials and Methods section. As shown in
Figure 6A, exposure of the mice to UVB irradiation confirmed sig-
nificant suppression (P < .001) of CHS (third bar) compared to the
positive control group of mice (second bar). Treatment of mice with
Figure 5. Effect of UVB irradiation on epigenetic regulators in COX-2–deficient mice. Mice were UVB irradiated on four consecutive days
with or without topical application of PGE2 and samples of the dorsal skin were taken 24 hours later, as described in Materials andMethods
section (n = 5). (A) The levels of global DNA methylation in the mouse skin were determined using a Global DNA Methylation Assay Kit.
In these mice, the UVB irradiation did not significantly affect the levels of global DNA methylation. Topical treatment of the UVB-exposed
mouse skin with PGE2 enhanced the levels of global DNA methylation. (B) The levels of 5-mC in the extracted DNA were estimated by dot-
blot analysis. (C) Total Dnmt activity in nuclear extracts of skin samples was determined using the Dnmt Activity Assay Kit. Topical treatment
of the UVB-exposed mouse skin with PGE2 increased Dnmt activity in the skin. Data are presented in terms of percentage versus non–UVB-
irradiated control group. Significantly higher activity versus mice exposed to UVB without topical application of PGE2, *P < .001. (D) The
levels of Dnmt1, Dnmt3a, and Dnmt3b proteins in the skin samples from the mice described in A were determined using Western blot
analysis. (E) The effect of topical treatment of PGE2 on DNA methylation levels in the wild-type littermates was determined. Significant
increase versus non–PGE2-treated mouse skin,
¶P < .01. (F, G) The expression of the transcription factors, Sp1 and Sp3, were determined
using Western blot analysis. (F) COX-2–deficient mice were resistant to UVB-induced increases in expression of Sp1 and Sp3 and topical
application of PGE2 in UVB-exposed COX-2–deficient mice resulted in overexpression of Sp1 and Sp3 transcription factors. (G) UVB
irradiation increased the expression of Sp1 and Sp3 in the skin of wild-type littermates of COX-2–deficient mice. Equal nuclear protein
loading on gels was verified using anti-histone H3 antibody.
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5-Aza-dc by i.p. injection after each UVB exposure resulted in signifi-
cant enhanced sensitization of mouse skin (P < .001) after challenge to
DNFB (fourth bar) compared to the CHS response in UVB-exposed
mice (third bar) that were not treated with 5-Aza-dc.
Effect of 5-Aza-dc on UVB-Induced DNA Methylation
and Dnmt Activity
To examine whether reversal of UVB-induced suppression of CHS
by 5-Aza-dc is associated with suppression of DNA methylation and
Dnmt activity, additional experiments were conducted. For this pur-
pose, C3H/HeN mice were exposed to UVB on four consecutive
days with and without treatment with 5-Aza-dc by i.p. injection, and
24 hours after the last UVB exposure, the mice were sacrificed and
skin samples were collected for the analysis of DNA methylation
and Dnmt activity. As shown in Figure 6, the results confirmed that
in the untreated mice UVB irradiation significantly increased the levels
of global DNAmethylation (Figure 6B) and Dnmt activity (Figure 6C)
in the UVB-exposed mice compared to non–UVB-exposed mouse
skin. The levels of global DNA methylation and Dnmt activity were
significantly lower (P < .01) in the UVB-exposed mice that were treated
with 5-Aza-dc than in the UVB-exposed mice that were not treated
with 5-Aza-dc. Western blot analysis of the levels of Dnmt proteins
in the skin lysate samples from the same treatment groups revealed
that the treatment of mice with 5-Aza-dc resulted in reduced expres-
sion of Dnmt1, Dnmt3a, and Dnmt3b proteins compared to the
levels in the skin of the non–5-Aza-dc–treated UVB-exposed mice
(Figure 6D).
Discussion
UV-induced PGE2 overproduction has been implicated in various
stages of tumor development, invasion, and metastasis of tumor cells
[8,24]; however, it is not yet clearly understood how PGE2 contributes
to the UV-induced immunosuppression and how the action of PGE2
is related to the other proposed mechanisms that have been implicated
in this process. In the present study, using a well-established CHS
protocol, we show that UV-induced suppression of CHS is associated
with the overexpression of COX-2, PGE2, and PGE2 receptors in
the mouse skin. Our study shows that treatment of mice with indo-
methacin, celecoxib, or antagonist of PGE2 receptor EP2 reverses or
blocks UVB radiation–induced immunosuppression in mice and thus
supports the concept that inhibitors of PGE2 or PGE2 signaling play a
crucial role in immunosuppression after UV irradiation. Under simi-
lar conditions, exposure of the skin to UVB enhanced expression of
Dnmt1, Dnmt3a, and Dnmt3b proteins as well as Dnmt activity,
which subsequently increased global DNA methylation. In the reverse
situation, treatment of mice with indomethacin or EP2 antagonist
(AH6809) decreased the levels of DNA methylation, Dnmt activity,
and the protein expressions of Dnmt1, Dnmt3a, and Dnmt3b in
UVB-exposed mouse skin. These data suggest that PGE2-mediated
DNA methylation may have a role in the suppression of the immune
system in UVB-irradiated mice.
To verify the role of PGE2 in UVB-induced immunosuppression,
we used COX-2–deficient mice, which were unable to synthesize
PGE2 after UVB irradiation. It was observed that COX-2–deficient
mice were resistant to UVB-induced suppression of CHS, whereas
the treatment of UVB-exposed COX-2–deficient mice with PGE2
resulted in suppression of CHS response, thus suggesting the role of
PGE2 in UVB-induced immunosuppression. To establish a link
between PGE2 and DNA hypermethylation in UVB-exposed skin,
COX-2–deficient mice that were treated with PGE2 were also treated
with DNA demethylating agent (5-Aza-dc) after UVB irradiation.
The treatment of mice with 5-Aza-dc resulted in full sensitization re-
action after DNFB challenge in PGE2-treated COX-2–deficient mice,
Figure 6. Effect of i.p. treatment of 5-Aza-dc on UVB-induced sup-
pression of CHS and DNA methylation. Mice were UVB irradiated
on four consecutive days with or without treatment with 5-Aza-dc.
The CHS response was measured as described in Materials and
Methods section (n = 4–5). (A) Injection of 5-Aza-dc after UVB irra-
diation reduced UVB-induced suppression of the CHS response or
restored the CHS response in UVB-irradiated mice. For the analysis
of epigenetic regulators, shaved mouse skin was UVB irradiated for
four consecutive days with and without the treatment of 5-Aza-dc.
Skin samples were collected 24 hours after the last UVB exposure.
Treatment of mice with 5-Aza-dc reduced (B) the levels of UVB-
induced global DNA methylation in UVB-irradiated mouse skin and
(C) Dnmt activity in UVB-irradiated mouse skin. Significant differ-
ence versus UVB irradiation in the absence of application of 5-Aza-dc,
*P < .01; and (D) the levels of Dnmt proteins, as determined by
Western blot analysis in UVB-irradiated mouse skin.
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thus suggesting the role of PGE2-mediated DNA hypermethylation in
UVB-induced immunosuppression.
The link between overexpression of PGE2 and DNA methylation
on exposure of the skin to UVB irradiation was further verified using
COX-2–deficient mice. A significant increase in DNA methylation
and Dnmt activity was not observed when COX-2–deficient mice were
irradiated multiple times to UVB radiation. However, the treatment
of these UVB-irradiated mice with PGE2 resulted in significant greater
Dnmt activity, overexpression of various Dnmt proteins (Dnmt1,
Dnmt3a, and Dnmt3b), and increased DNA methylation compared to
the mice that were exposed to UVB but were not treated with PGE2.
Epigenetic alterations including DNA hypermethylation or hypo-
methylation have been implicated in tumor growth and progression
including the skin tumors in mice and humans [10]. The role of inflam-
matory mediators such as PGE2 in UV irradiation–induced immuno-
suppression has been indicated by studies showing that NSAIDs that
exert their effect through COX-2 inhibition can reverse the immuno-
suppressive effect of UV radiation [4,5]. We therefore further tried to
establish a link between DNA methylation and UVB-induced immuno-
suppression. For this purpose, C3H/HeN mice were exposed to UVB
radiation with or without treatment with a DNA demethylating agent
(5-Aza-dc) and CHS response was evaluated. The results demonstrate
that treatment of mice with 5-Aza-dc reversed or inhibited UVB-induced
suppression of CHS response to DNFB accompanied with lowering
the levels of global DNA methylation, Dnmt activity, and the protein
expressions of Dnmt1, Dnmt3a, and Dnmt3b compared to non–5-
Aza-dc–treated UVB-exposed mice. It was interesting to note that the
expression of Dnmt3a was greater in PGE2-treated mice.
Several immunomodulatory mediators have been shown to play a
role in the UV-induced immunosuppression [13,14,25–27]. Previ-
ously, we have shown that the UV-induced suppression of CHS is
associated with an imbalance of interleukin-10 and interleukin-12
[13] and that the repair of UV-induced DNA damage in the form of
cyclobutane pyrimidine dimers and nucleotide excision repair mecha-
nisms play a role in this process [14]. The current study clearly implicates
PGE2, which is known to affect multiple immune and inflammatory
factors. This suggests that exposure of skin to UVB radiation can induce
immune suppression by different events that trigger widespread dis-
ruption of immune and inflammatory response. Elucidation of the
relative roles of these events and their interactions in the context of dose
responses and genetic predisposition requires further study.
The findings of the current studies have significant clinical relevance
as PGE2 generation is upregulated in inflammation, infection, and
cancer. In general, the outcome of our findings allow us to speculate
that changes in PGE2 biosynthesis may contribute to changes in DNA
methylation patterns associated with a wide variety of diseases includ-
ing the various skin diseases associated with chronic exposure to sun-
light and other environmental factors. Collectively, the results of our
study demonstrate the role of PGE2-mediated DNA methylation in
UVB-induced immunosuppression. UV-induced immunosuppression
has been considered as a risk factor in nonmelanoma skin cancers caused
by excessive exposure to UV radiation [1,28], and the incidence of non-
melanoma skin cancer was reduced in subjects receiving a selective
COX-2 inhibitor (celecoxib) compared to subjects receiving placebo
[9]. Therefore, the outcome of our study not only provides substantial
insight into the intricate roles of PGE2 in UVB-induced immuno-
suppression and how DNA methylation is regulated by PGE2 in
UVB-exposed skin but also provide a rationale for considering the devel-
opment of new strategies using the inhibitors of PGE2 and demethylat-
ing agents alone or in combination for the prevention or treatment of
nonmelanoma skin cancers.
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